Barclays PLC Exact Sciences Corp Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

21 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$42.43 - $70.83 $2.04 Million - $3.4 Million	48,000 New	48,000 $3.27 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $2.98 Million - $3.91 Million	53,000 Added 530.0%	63,000 $4.35 Million
Q4 2023 Feb 15, 2024	SELL	$59.06 - $75.72 $8.03 Million - $10.3 Million	-136,000 Reduced 93.15%	10,000 $740,000
Q3 2023 Nov 07, 2023	BUY	$65.94 - $99.04 $9.63 Million - $14.5 Million	146,000 New	146,000 $9.96 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $1.45 Million - $2.01 Million	20,000 Added 34.48%	78,000 $6.07 Million
Q3 2021 Nov 09, 2021	BUY	$90.24 - $124.05 $81,216 - $111,645	900 Added 1.58%	58,000 $5.54 Million
Q2 2021 Aug 13, 2021	SELL	$93.66 - $139.27 $1.61 Million - $2.4 Million	-17,200 Reduced 23.15%	57,100 $7.1 Million
Q1 2021 May 13, 2021	BUY	$116.57 - $155.01 $5.4 Million - $7.18 Million	46,300 Added 165.36%	74,300 $9.79 Million
Q4 2020 Feb 11, 2021	SELL	$99.61 - $142.12 $328,713 - $468,996	-3,300 Reduced 10.54%	28,000 $3.71 Million
Q2 2020 Aug 12, 2020	SELL	$55.75 - $92.75 $4.89 Million - $8.13 Million	-87,700 Reduced 73.7%	31,300 $2.72 Million
Q1 2020 May 13, 2020	SELL	$37.9 - $104.44 $1.71 Million - $4.72 Million	-45,200 Reduced 27.53%	119,000 $6.9 Million
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $2.16 Million - $2.77 Million	27,800 Added 20.38%	164,200 $15.2 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $3.79 Million - $5.13 Million	41,900 Added 44.34%	136,400 $12.3 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $9.17 Million - $12.1 Million	-102,400 Reduced 52.01%	94,500 $11.2 Million
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $2.82 Million - $4.39 Million	-45,500 Reduced 18.77%	196,900 $17.1 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $9.63 Million - $14.2 Million	-171,900 Reduced 41.49%	242,400 $15.3 Million
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $9.82 Million - $16.4 Million	203,300 Added 96.35%	414,300 $32.7 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $4.46 Million - $8.24 Million	117,800 Added 126.39%	211,000 $12.6 Million
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $1.49 Million - $2.16 Million	37,500 Added 67.32%	93,200 $3.76 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $6.15 Million - $8.01 Million	-132,300 Reduced 70.37%	55,700 $2.93 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $6.97 Million - $8.86 Million	188,000	188,000 $8.86 Million

Others Institutions Holding EXAS

# of Institutions

674

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.08 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$959 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$868 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$731 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$405 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account